<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39361890</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-2423</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>03</Day></PubDate></JournalIssue><Title>Glycobiology</Title><ISOAbbreviation>Glycobiology</ISOAbbreviation></Journal><ArticleTitle>Diversity of human salivary heparan sulfate.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">cwae084</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/glycob/cwae084</ELocationID><Abstract><AbstractText>The human oral cavity and upper airway serves as an early barrier and reservoir in the transmission of SARS-CoV-2. Saliva in this microenvironment may serve as a key host factor that can modulate susceptibility to infection and eventual infection of the lower respiratory tract. We sought to analyze the content and composition of heparan sulfate, a glycosaminoglycan identified as an important co-receptor for viral entry, and whether there is any correlation with SARS-CoV-2 infection. We enlisted 98 participants stratified by age, gender, race, and COVID-19 history. Notably, the concentration of heparan sulfate in saliva increased with age, and its composition showed a wide range of variability within each age group independently of age. Heparan sulfate concentration and composition did not differ significantly with gender, ethnicity or race. Compared to patients with no COVID-19 history, patients with previous infection had a similar salivary heparan sulfate concentration, but significant increases in overall sulfation were noted. Moreover, in a subset of participants, for which data was available pre- and post- infection, significant elevation in N-sulfoglucosamine in heparan sulfate was observed post- COVID-19. Examination of salivary bacterial 16S rRNA, showed a significant reduction in species predicted to possess heparan sulfate-modifying capacity among participants &gt;60 years old, which correlates with the increase in heparan sulfate content in older individuals. These findings demonstrate a surprisingly wide variation in heparan sulfate content and composition in saliva across the sampled population and confirm other findings showing variation in content and composition of glycosaminoglycans in blood and urine.</AbstractText><CopyrightInformation>© The Author(s) 2024. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Spliid</LastName><ForeName>Charlotte B</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA San Diego Healthcare System and Veterans Medical Research Foundation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuster</LastName><ForeName>Mark M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>VA San Diego Healthcare System and Veterans Medical Research Foundation.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Division of Pulmonary &amp; Critical Care, University of California San Diego, La Jolla, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martino</LastName><ForeName>Cameron</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, CA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Microbiome Innovation, University of California San Diego, La Jolla, CA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Claire L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Nharae</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Florentino</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Khang</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Altman Clinical and Translational Research Institute, University of California San Diego, La Jolla, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ackermann</LastName><ForeName>Gail</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knight</LastName><ForeName>Rob</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, CA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Microbiome Innovation, University of California San Diego, La Jolla, CA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Bioengineering, University of California San Diego, La Jolla, CA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science and Engineering, University of California San Diego, La Jolla, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esko</LastName><ForeName>Jeffrey D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Mendoza</LastName><ForeName>Tatiana Hurtado</ForeName><Initials>TH</Initials><Identifier Source="ORCID">0000-0003-3805-9254</Identifier><AffiliationInfo><Affiliation>Department of Surgery, University of California San Diego, Moores Cancer Center, La Jolla, CA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Glycobiology</MedlineTA><NlmUniqueID>9104124</NlmUniqueID><ISSNLinking>0959-6658</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Covid-19</Keyword><Keyword MajorTopicYN="N">age</Keyword><Keyword MajorTopicYN="N">heparan sulfate</Keyword><Keyword MajorTopicYN="N">microbiome</Keyword><Keyword MajorTopicYN="N">saliva</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>7</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>7</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>15</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39361890</ArticleId><ArticleId IdType="doi">10.1093/glycob/cwae084</ArticleId><ArticleId IdType="pii">7810227</ArticleId></ArticleIdList></PubmedData></PubmedArticle>